(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXO32 mRNA] CTD PMID:31150632 (S)-(-)-perillyl alcohol increases expression ISO Fbxo32 (Mus musculus) 6480464 perillyl alcohol results in increased expression of FBXO32 mRNA and perillyl alcohol results in increased expression of FBXO32 protein CTD PMID:19406843 1,2-dichloroethane decreases expression ISO Fbxo32 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of FBXO32 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO Fbxo32 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of FBXO32 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO FBXO32 (Homo sapiens) 6480464 Estradiol results in increased expression of FBXO32 mRNA CTD PMID:16474171 17beta-estradiol decreases expression ISO FBXO32 (Homo sapiens) 6480464 Estradiol results in decreased expression of FBXO32 mRNA CTD PMID:24758408 and PMID:31614463 17beta-estradiol multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA more ... CTD PMID:23275455 and PMID:24758408 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO FBXO32 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FBXO32 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA CTD PMID:33387578 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO FBXO32 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA CTD PMID:30096437 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fbxo32 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FBXO32 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fbxo32 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA CTD PMID:19933214 2-butoxyethanol decreases expression ISO Fbxo32 (Mus musculus) 6480464 n-butoxyethanol results in decreased expression of FBXO32 mRNA CTD PMID:19812364 2-hydroxypropanoic acid decreases expression ISO FBXO32 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of FBXO32 mRNA CTD PMID:30851411 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO Fbxo32 (Mus musculus) 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA] and geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] CTD PMID:19406843 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Fbxo32 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of FBXO32 mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression ISO Fbxo32 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of FBXO32 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of FBXO32 mRNA CTD PMID:28522335 3-hydroxyisovaleric acid increases expression EXP 6480464 beta-hydroxyisovaleric acid results in increased expression of FBXO32 mRNA CTD PMID:24124592 3-hydroxyisovaleric acid multiple interactions EXP 6480464 beta-hydroxyisovaleric acid inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:24124592 4,4'-diaminodiphenylmethane decreases expression ISO Fbxo32 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of FBXO32 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO Fbxo32 (Mus musculus) 6480464 bisphenol S results in increased expression of FBXO32 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO Fbxo32 (Mus musculus) 6480464 Fenretinide results in increased expression of FBXO32 mRNA CTD PMID:28973697 4-nitrophenol decreases expression ISO Fbxo32 (Mus musculus) 6480464 4-nitrophenol results in decreased expression of FBXO32 mRNA CTD PMID:34673133 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of FBXO32 protein] CTD PMID:30980806 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [6-chloro-2 more ... CTD PMID:22146233 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FBXO32 mRNA CTD PMID:24780913 6alpha-methylprednisolone increases expression EXP 6480464 Methylprednisolone results in increased expression of FBXO32 protein CTD PMID:21931329 6alpha-methylprednisolone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Methylprednisolone results in increased expression of FBXO32 protein] CTD PMID:21931329 8-Br-cAMP multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA and NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA] CTD PMID:23275455 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of FBXO32 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO FBXO32 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of FBXO32 mRNA CTD PMID:22100608 aflatoxin B1 increases methylation ISO FBXO32 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of FBXO32 gene CTD PMID:27153756 aldehydo-D-glucose multiple interactions ISO Fbxo32 (Mus musculus) 6480464 FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein] CTD PMID:30635400 aldehydo-D-glucose increases expression ISO Fbxo32 (Mus musculus) 6480464 Glucose results in increased expression of FBXO32 protein CTD PMID:30635400 all-trans-retinoic acid multiple interactions ISO Fbxo32 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FBXO32 mRNA CTD PMID:36189433 amiodarone increases expression ISO FBXO32 (Homo sapiens) 6480464 Amiodarone results in increased expression of FBXO32 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FBXO32 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of FBXO32 mRNA CTD PMID:30779732 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Fbxo32 (Mus musculus) 6480464 pyrazolanthrone inhibits the reaction [Indican results in increased expression of FBXO32 protein] CTD PMID:30849338 aristolochic acid A increases expression ISO FBXO32 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of FBXO32 mRNA CTD PMID:33212167 arotinoid acid multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane affects expression ISO FBXO32 (Homo sapiens) 6480464 Arsenic affects the expression of FBXO32 mRNA CTD PMID:18414638 arsane multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FBXO32 mRNA CTD PMID:32525701 arsane affects methylation ISO FBXO32 (Homo sapiens) 6480464 Arsenic affects the methylation of FBXO32 gene CTD PMID:25304211 arsenic atom affects expression ISO FBXO32 (Homo sapiens) 6480464 Arsenic affects the expression of FBXO32 mRNA CTD PMID:18414638 arsenic atom multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FBXO32 mRNA CTD PMID:32525701 arsenic atom affects methylation ISO FBXO32 (Homo sapiens) 6480464 Arsenic affects the methylation of FBXO32 gene CTD PMID:25304211 arsenous acid increases expression ISO Fbxo32 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of FBXO32 protein CTD PMID:32184170 and PMID:32635466 arsenous acid increases expression ISO FBXO32 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of FBXO32 mRNA CTD PMID:24356939 atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of FBXO32 mRNA CTD PMID:27377005 avobenzone increases expression ISO FBXO32 (Homo sapiens) 6480464 avobenzone results in increased expression of FBXO32 mRNA CTD PMID:31016361 benzo[a]pyrene decreases expression ISO FBXO32 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of FBXO32 mRNA CTD PMID:20106945 benzo[a]pyrene decreases methylation ISO FBXO32 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of FBXO32 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO FBXO32 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of FBXO32 3' UTR and Benzo(a)pyrene results in increased methylation of FBXO32 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Fbxo32 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of FBXO32 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO Fbxo32 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of FBXO32 mRNA CTD PMID:21715664 bis(2-chloroethyl) sulfide increases expression ISO FBXO32 (Homo sapiens) 6480464 Mustard Gas results in increased expression of FBXO32 mRNA CTD PMID:25102026 bisphenol A increases expression ISO Fbxo32 (Mus musculus) 6480464 bisphenol A results in increased expression of FBXO32 mRNA CTD PMID:26063408 bisphenol A multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO32 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FBXO32 mRNA CTD PMID:30816183 and PMID:32528016 bisphenol A increases expression ISO FBXO32 (Homo sapiens) 6480464 bisphenol A results in increased expression of FBXO32 mRNA CTD PMID:16474171 more ... Botulinum toxin type A multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Ouabain affects the reaction [Botulinum Toxins and Type A affects the expression of FBXO32 mRNA] CTD PMID:21139329 Botulinum toxin type A affects expression ISO Fbxo32 (Mus musculus) 6480464 Botulinum Toxins and Type A affects the expression of FBXO32 mRNA CTD PMID:21139329 cadmium atom multiple interactions ISO Fbxo32 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXO32 mRNA CTD PMID:37325564 cadmium dichloride multiple interactions ISO Fbxo32 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXO32 mRNA CTD PMID:37325564 calcitriol decreases expression ISO FBXO32 (Homo sapiens) 6480464 Calcitriol results in decreased expression of FBXO32 mRNA CTD PMID:16002434 calcitriol multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Calcitriol inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:29962435 cannabidiol increases expression ISO FBXO32 (Homo sapiens) 6480464 Cannabidiol results in increased expression of FBXO32 mRNA CTD PMID:26504004 cannabidiol multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [Dronabinol co-treated with Cannabidiol] results in increased expression of FBXO32 mRNA CTD PMID:26504004 cantharidin decreases expression ISO Fbxo32 (Mus musculus) 6480464 Cantharidin results in decreased expression of FBXO32 mRNA CTD PMID:36907384 carbon nanotube affects expression ISO Fbxo32 (Mus musculus) 6480464 Nanotubes and Carbon analog affects the expression of FBXO32 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO Fbxo32 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of FBXO32 mRNA CTD PMID:25554681 carmustine affects response to substance ISO FBXO32 (Homo sapiens) 6480464 FBXO32 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 celastrol decreases expression EXP 6480464 celastrol results in decreased expression of FBXO32 protein CTD PMID:25903958 celastrol multiple interactions EXP 6480464 HSPA1A protein affects the reaction [celastrol results in decreased expression of FBXO32 protein] CTD PMID:25903958 CGP 52608 multiple interactions ISO FBXO32 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to FBXO32 gene] CTD PMID:28238834 CHIR 99021 decreases expression ISO Fbxo32 (Mus musculus) 6480464 Chir 99021 results in decreased expression of FBXO32 mRNA CTD PMID:21832246 CHIR 99021 multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 CHIR 99021 multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Chir 99021 inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:21832246 chlordecone increases expression ISO Fbxo32 (Mus musculus) 6480464 Chlordecone results in increased expression of FBXO32 mRNA CTD PMID:33711761 chloroquine affects expression EXP 6480464 Chloroquine affects the expression of FBXO32 mRNA CTD PMID:19296457 chlorpyrifos decreases expression ISO Fbxo32 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of FBXO32 mRNA CTD PMID:37019170 choline multiple interactions ISO Fbxo32 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBXO32 mRNA CTD PMID:20938992 chromium atom decreases expression EXP 6480464 Chromium deficiency results in decreased expression of FBXO32 mRNA and Chromium results in decreased expression of FBXO32 protein CTD PMID:19071005 and PMID:20404053 cisplatin increases expression ISO Fbxo32 (Mus musculus) 6480464 Cisplatin results in increased expression of FBXO32 and Cisplatin results in increased expression of FBXO32 mRNA CTD PMID:21074548 more ... cobalt dichloride increases expression ISO Fbxo32 (Mus musculus) 6480464 cobaltous chloride results in increased expression of FBXO32 protein CTD PMID:23684559 copper(II) sulfate increases expression ISO FBXO32 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of FBXO32 mRNA CTD PMID:19549813 cortisol multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of FBXO32 mRNA CTD PMID:27523638 cyclosporin A increases expression ISO FBXO32 (Homo sapiens) 6480464 Cyclosporine results in increased expression of FBXO32 mRNA CTD PMID:25562108 and PMID:27989131 D-glucose increases expression ISO Fbxo32 (Mus musculus) 6480464 Glucose results in increased expression of FBXO32 protein CTD PMID:30635400 D-glucose multiple interactions ISO Fbxo32 (Mus musculus) 6480464 FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein] CTD PMID:30635400 DDT decreases expression EXP 6480464 DDT results in decreased expression of FBXO32 mRNA CTD PMID:30207508 dexamethasone multiple interactions ISO Fbxo32 (Mus musculus) 6480464 (+)-JQ1 compound inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] more ... CTD PMID:19032942 more ... dexamethasone increases expression ISO Fbxo32 (Mus musculus) 6480464 Dexamethasone results in increased expression of FBXO32 mRNA and Dexamethasone results in increased expression of FBXO32 protein CTD PMID:19032942 more ... dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of FBXO32 mRNA CTD PMID:18436443 and PMID:24124592 dexamethasone multiple interactions EXP 6480464 beta-hydroxyisovaleric acid inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] and Testosterone inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:18436443 and PMID:24124592 diarsenic trioxide increases expression ISO Fbxo32 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of FBXO32 protein CTD PMID:32184170 and PMID:32635466 diarsenic trioxide increases expression ISO FBXO32 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of FBXO32 mRNA CTD PMID:24356939 diazinon increases methylation ISO FBXO32 (Homo sapiens) 6480464 Diazinon results in increased methylation of FBXO32 gene CTD PMID:22964155 dibutyl phthalate decreases expression ISO Fbxo32 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of FBXO32 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of FBXO32 mRNA CTD PMID:21266533 dioxygen increases expression ISO Fbxo32 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of FBXO32 mRNA CTD PMID:23624791 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FBXO32 mRNA CTD PMID:33729688 dioxygen multiple interactions ISO Fbxo32 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO32 mRNA CTD PMID:30529165 dioxygen increases expression ISO FBXO32 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of FBXO32 mRNA CTD PMID:26516004 disodium selenite increases expression ISO FBXO32 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of FBXO32 mRNA CTD PMID:18175754 and PMID:24383545 doxorubicin multiple interactions EXP 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased expression of FBXO32 mRNA] and AKT1 protein inhibits the reaction [Doxorubicin results in increased expression of FBXO32 mRNA] CTD PMID:18346979 doxorubicin increases expression ISO FBXO32 (Homo sapiens) 6480464 Doxorubicin results in increased expression of FBXO32 mRNA CTD PMID:29803840 doxorubicin affects expression ISO FBXO32 (Homo sapiens) 6480464 Doxorubicin affects the expression of FBXO32 mRNA CTD PMID:25529476 doxorubicin increases expression ISO Fbxo32 (Mus musculus) 6480464 Doxorubicin results in increased expression of FBXO32 mRNA and Doxorubicin results in increased expression of FBXO32 protein CTD PMID:23639627 and PMID:25896364 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of FBXO32 mRNA and Doxorubicin results in increased expression of FBXO32 protein CTD PMID:18346979 and PMID:23639627 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FBXO32 mRNA CTD PMID:29391264 ethanol affects splicing ISO Fbxo32 (Mus musculus) 6480464 Ethanol affects the splicing of FBXO32 mRNA CTD PMID:30319688 fenofibrate multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Lovastatin promotes the reaction [Fenofibrate results in increased expression of FBXO32 protein] and PPARA protein affects the reaction [Fenofibrate results in increased expression of FBXO32 mRNA] CTD PMID:33408297 fenofibrate increases expression ISO Fbxo32 (Mus musculus) 6480464 Fenofibrate results in increased expression of FBXO32 mRNA and Fenofibrate results in increased expression of FBXO32 protein CTD PMID:33408297 fluoranthene multiple interactions ISO Fbxo32 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of FBXO32 mRNA CTD PMID:28329830 folic acid multiple interactions ISO Fbxo32 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBXO32 mRNA CTD PMID:20938992 fulvestrant multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO32 gene CTD PMID:31601247 gamma-hexachlorocyclohexane increases expression ISO FBXO32 (Homo sapiens) 6480464 Hexachlorocyclohexane results in increased expression of FBXO32 mRNA CTD PMID:24356939 genistein increases expression ISO FBXO32 (Homo sapiens) 6480464 Genistein results in increased expression of FBXO32 mRNA CTD PMID:16474171 glucose multiple interactions ISO Fbxo32 (Mus musculus) 6480464 FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein] CTD PMID:30635400 glucose increases expression ISO Fbxo32 (Mus musculus) 6480464 Glucose results in increased expression of FBXO32 protein CTD PMID:30635400 hexadecanoic acid increases expression ISO Fbxo32 (Mus musculus) 6480464 Palmitic Acid results in increased expression of FBXO32 mRNA CTD PMID:25614714 hexadecanoic acid multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Quercetin inhibits the reaction [Palmitic Acid results in increased expression of FBXO32 mRNA] CTD PMID:25614714 indoxyl sulfate multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Indican results in increased expression of FBXO32 protein] and pyrazolanthrone inhibits the reaction [Indican results in increased expression of FBXO32 protein] CTD PMID:30849338 indoxyl sulfate increases expression ISO Fbxo32 (Mus musculus) 6480464 Indican results in increased expression of FBXO32 mRNA and Indican results in increased expression of FBXO32 protein CTD PMID:29380555 and PMID:30849338 isoprenaline increases expression ISO Fbxo32 (Mus musculus) 6480464 Isoproterenol results in increased expression of FBXO32 mRNA CTD PMID:20003209 L-ascorbic acid multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FBXO32 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FBXO32 mRNA CTD PMID:34480604 L-methionine multiple interactions ISO Fbxo32 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBXO32 mRNA CTD PMID:20938992 lead diacetate increases expression ISO Fbxo32 (Mus musculus) 6480464 lead acetate results in increased expression of FBXO32 mRNA CTD PMID:20542052 Licochalcone B increases expression ISO FBXO32 (Homo sapiens) 6480464 licochalcone B results in increased expression of FBXO32 mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO Fbxo32 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of FBXO32 mRNA CTD PMID:17131360 lithium chloride decreases expression ISO Fbxo32 (Mus musculus) 6480464 Lithium Chloride results in decreased expression of FBXO32 mRNA CTD PMID:21832246 lovastatin multiple interactions ISO Fbxo32 (Mus musculus) 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA] more ... CTD PMID:19406843 and PMID:33408297 lovastatin increases expression ISO Fbxo32 (Mus musculus) 6480464 Lovastatin results in increased expression of FBXO32 mRNA and Lovastatin results in increased expression of FBXO32 protein CTD PMID:19406843 LY294002 decreases expression ISO Fbxo32 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FBXO32 mRNA CTD PMID:21832246 metformin decreases expression EXP 6480464 Metformin results in decreased expression of FBXO32 mRNA CTD PMID:31324951 methamphetamine increases expression ISO Fbxo32 (Mus musculus) 6480464 Methamphetamine results in increased expression of FBXO32 mRNA CTD PMID:23933405 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of FBXO32 gene CTD PMID:35440735 methylmercury chloride increases expression ISO FBXO32 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of FBXO32 mRNA CTD PMID:28001369 mevalonic acid multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA] and Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] CTD PMID:19406843 mono(2-ethylhexyl) phthalate multiple interactions ISO Fbxo32 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FBXO32 mRNA CTD PMID:36189433 monocrotaline multiple interactions EXP 6480464 resveratrol inhibits the reaction [Monocrotaline results in decreased expression of FBXO32 mRNA] CTD PMID:22146233 monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of FBXO32 mRNA CTD PMID:18801959 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of FBXO32 mRNA CTD PMID:22146233 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of FBXO32 mRNA CTD PMID:21515302 N-acetyl-L-cysteine multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Indican results in increased expression of FBXO32 protein] CTD PMID:30849338 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO Fbxo32 (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [FBXO32 protein results in decreased expression of KCNN2 protein] CTD PMID:30635400 nickel atom decreases expression ISO FBXO32 (Homo sapiens) 6480464 Nickel results in decreased expression of FBXO32 mRNA CTD PMID:24768652 nickel dichloride increases expression ISO FBXO32 (Homo sapiens) 6480464 nickel chloride results in increased expression of FBXO32 mRNA CTD PMID:21455298 nickel sulfate increases expression ISO FBXO32 (Homo sapiens) 6480464 nickel sulfate results in increased expression of FBXO32 mRNA CTD PMID:22714537 ochratoxin A decreases expression ISO FBXO32 (Homo sapiens) 6480464 ochratoxin A metabolite results in decreased expression of FBXO32 mRNA CTD PMID:24356939 ouabain multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Ouabain affects the reaction [Botulinum Toxins and Type A affects the expression of FBXO32 mRNA] CTD PMID:21139329 ozone multiple interactions ISO Fbxo32 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FBXO32 mRNA CTD PMID:27106289 paraquat multiple interactions ISO Fbxo32 (Mus musculus) 6480464 ST2825 inhibits the reaction [Paraquat results in increased expression of FBXO32 mRNA] CTD PMID:34811946 paraquat increases expression ISO Fbxo32 (Mus musculus) 6480464 Paraquat results in increased expression of FBXO32 mRNA CTD PMID:34811946 perfluorohexanesulfonic acid decreases expression ISO FBXO32 (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO FBXO32 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid decreases expression ISO FBXO32 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO FBXO32 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 perillyl alcohol increases expression ISO Fbxo32 (Mus musculus) 6480464 perillyl alcohol results in increased expression of FBXO32 mRNA and perillyl alcohol results in increased expression of FBXO32 protein CTD PMID:19406843 phenethyl isothiocyanate increases expression ISO FBXO32 (Homo sapiens) 6480464 phenethyl isothiocyanate results in increased expression of FBXO32 mRNA CTD PMID:26678675 phenobarbital affects expression ISO FBXO32 (Homo sapiens) 6480464 Phenobarbital affects the expression of FBXO32 mRNA CTD PMID:19159669 potassium chromate decreases expression ISO FBXO32 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of FBXO32 mRNA CTD PMID:22714537 progesterone multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA and NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA] CTD PMID:23275455 quercetin multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Quercetin inhibits the reaction [Dietary Fats results in increased expression of FBXO32 mRNA] and Quercetin inhibits the reaction [Palmitic Acid results in increased expression of FBXO32 mRNA] CTD PMID:25614714 rac-lactic acid decreases expression ISO FBXO32 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of FBXO32 mRNA CTD PMID:30851411 resveratrol multiple interactions EXP 6480464 [resveratrol results in increased localization of and results in increased activity of FOXO1 protein] which results in increased expression of FBXO32 mRNA and resveratrol inhibits the reaction [Monocrotaline results in decreased expression of FBXO32 mRNA] CTD PMID:18077353 and PMID:22146233 resveratrol multiple interactions ISO Fbxo32 (Mus musculus) 6480464 FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of FBXO32 mRNA]] more ... CTD PMID:24534773 resveratrol decreases expression ISO FBXO32 (Homo sapiens) 6480464 resveratrol results in decreased expression of FBXO32 mRNA CTD PMID:25888808 resveratrol increases expression ISO FBXO32 (Homo sapiens) 6480464 resveratrol results in increased expression of FBXO32 mRNA CTD PMID:22146233 SB 431542 multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of FBXO32 mRNA CTD PMID:34480604 simvastatin increases expression ISO Fbxo32 (Mus musculus) 6480464 Simvastatin results in increased expression of FBXO32 mRNA and Simvastatin results in increased expression of FBXO32 protein CTD PMID:25300705 more ... simvastatin multiple interactions ISO Fbxo32 (Mus musculus) 6480464 FST protein inhibits the reaction [Simvastatin results in increased expression of FBXO32 mRNA] more ... CTD PMID:27734117 and PMID:33034787 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of FBXO32 mRNA CTD PMID:19001041 and PMID:25300705 sirolimus multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [(+)-JQ1 compound co-treated with Sirolimus] affects the expression of FBXO32 mRNA and Sirolimus inhibits the reaction [TP73 protein results in increased expression of FBXO32 mRNA] CTD PMID:21245298 and PMID:25307878 sirolimus increases expression ISO FBXO32 (Homo sapiens) 6480464 Sirolimus results in increased expression of FBXO32 mRNA CTD PMID:24356939 sirtinol multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [sirtinol results in decreased activity of SIRT1 protein] which results in decreased expression of FBXO32 mRNA CTD PMID:22146233 sodium arsenate increases expression ISO Fbxo32 (Mus musculus) 6480464 sodium arsenate results in increased expression of FBXO32 mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FBXO32 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO FBXO32 (Homo sapiens) 6480464 sodium arsenite results in increased expression of FBXO32 mRNA CTD PMID:22714537 and PMID:23876855 sodium arsenite decreases expression ISO FBXO32 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of FBXO32 mRNA CTD PMID:34032870 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of FBXO32 protein CTD PMID:30980806 streptozocin increases expression ISO Fbxo32 (Mus musculus) 6480464 Streptozocin results in increased expression of FBXO32 protein CTD PMID:30635400 streptozocin multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of FBXO32 protein] CTD PMID:30980806 sulforaphane decreases expression ISO FBXO32 (Homo sapiens) 6480464 sulforaphane results in decreased expression of FBXO32 mRNA CTD PMID:31838189 sunitinib increases expression ISO Fbxo32 (Mus musculus) 6480464 Sunitinib results in increased expression of FBXO32 mRNA CTD PMID:31445075 sunitinib increases expression ISO FBXO32 (Homo sapiens) 6480464 Sunitinib results in increased expression of FBXO32 mRNA CTD PMID:31533062 temozolomide affects response to substance ISO FBXO32 (Homo sapiens) 6480464 FBXO32 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide increases expression ISO FBXO32 (Homo sapiens) 6480464 Temozolomide results in increased expression of FBXO32 mRNA CTD PMID:31758290 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of FBXO32 mRNA CTD PMID:21515302 testosterone affects expression ISO Fbxo32 (Mus musculus) 6480464 Testosterone affects the expression of FBXO32 mRNA CTD PMID:20403060 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] and Testosterone inhibits the reaction [Methylprednisolone results in increased expression of FBXO32 protein] CTD PMID:18436443 and PMID:21931329 testosterone increases expression EXP 6480464 Testosterone deficiency results in increased expression of FBXO32 mRNA and Testosterone deficiency results in increased expression of FBXO32 protein CTD PMID:19926828 testosterone multiple interactions ISO Fbxo32 (Mus musculus) 6480464 Testosterone inhibits the reaction [Testosterone deficiency results in increased expression of FBXO32 mRNA] CTD PMID:21045173 testosterone increases expression ISO Fbxo32 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of FBXO32 mRNA and Testosterone results in increased expression of FBXO32 mRNA CTD PMID:20403060 and PMID:21045173 tetrachloro-1,4-benzoquinone increases expression ISO FBXO32 (Homo sapiens) 6480464 Chloranil results in increased expression of FBXO32 mRNA CTD PMID:24214992 tetrachloroethene increases expression ISO Fbxo32 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of FBXO32 mRNA CTD PMID:28973375 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXO32 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FBXO32 mRNA CTD PMID:31150632 thapsigargin increases expression ISO FBXO32 (Homo sapiens) 6480464 Thapsigargin results in increased expression of FBXO32 mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FBXO32 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Fbxo32 (Mus musculus) 6480464 titanium dioxide results in increased expression of FBXO32 mRNA CTD PMID:23557971 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of FBXO32 mRNA CTD PMID:33387578 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of FBXO32 mRNA CTD PMID:21515302 tungsten decreases expression ISO Fbxo32 (Mus musculus) 6480464 Tungsten results in decreased expression of FBXO32 mRNA CTD PMID:30912803 tunicamycin increases expression ISO FBXO32 (Homo sapiens) 6480464 Tunicamycin results in increased expression of FBXO32 mRNA CTD PMID:22378314 urethane increases expression ISO FBXO32 (Homo sapiens) 6480464 Urethane results in increased expression of FBXO32 mRNA CTD PMID:28818685 valproic acid increases expression ISO FBXO32 (Homo sapiens) 6480464 Valproic Acid results in increased expression of FBXO32 mRNA CTD PMID:28001369 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of FBXO32 mRNA CTD PMID:23034163 XAV939 multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FBXO32 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FBXO32 mRNA CTD PMID:34480604 zinc atom multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FBXO32 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO FBXO32 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FBXO32 mRNA CTD PMID:18593933